Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/10795/000001079518000036/bdx2018-09x3010xk.htm
Exhibit 99.1
1 Becton Drive
Franklin Lakes, NJ 07417
www.bd.com
Contact:
Monique N. Dolecki, Investor Relations - 201-847-5378
Kristen Cardillo, Corporate Communications - 201-847-5657
BD ANNOUNCES RESULTS FOR 2018 FOURTH FISCAL QUARTER AND FULL YEAR;
PROVIDES FISCAL 2019 GUIDANCE
• | As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent. |
• | On a comparable, currency-neutral basis, revenues increased 5.8 percent for the full fiscal year. |
• | As reported, full fiscal year diluted earnings per share of $0.60 decreased 87.0 percent. |
• | As adjusted, full fiscal year diluted earnings per share of $11.01 increased 16.1 percent, or 12.3 percent on a currency-neutral basis. |
• | The company expects full fiscal year 2019 revenues to increase 8.5 to 9.5 percent as reported, or 5.0 to 6.0 percent on a comparable, currency-neutral basis. |
• | As adjusted, the company expects full fiscal year 2019 diluted earnings per share to be between $12.05 and $12.15, resulting in growth of approximately 13.0 to 14.0 percent on a currency-neutral basis, which includes an adverse impact of approximately 600 basis points related to headwinds and divestitures. This represents growth of approximately 10.0 percent including the estimated unfavorable impact of foreign currency. |
• | Fiscal 2019 earnings per share expectations include high-single digit accretion from the C. R. Bard acquisition. |
Franklin Lakes, NJ (November 6, 2018) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for the fourth fiscal quarter ended September 30, 2018. This represents an increase of 39.0 percent from the prior-year period, which is primarily due to the acquisition of C. R. Bard. On a comparable, currency-neutral basis that includes the revenues of C. R. Bard in the current and prior year, fourth quarter revenues increased 8.4 percent over the prior-year period. For the full fiscal year ended September 30, 2018, revenues of $15.983 billion increased 32.2 percent from the prior-year period, primarily due to the acquisition of C. R. Bard. On a comparable, currency-neutral basis that includes the revenues of C. R. Bard in the current and prior year, full fiscal year revenues of $16.930 billion grew 5.8 percent. This includes an estimated 60 basis point adverse impact from the previously disclosed change in the U.S. dispensing business model and the estimated sales impact from Hurricane Maria in Puerto Rico on Bard's business during BD's first fiscal quarter.
“Fiscal 2018 was a historic year for BD with the successful completion of the acquisition of C. R. Bard. We are extremely proud of our strong fourth quarter and fiscal year results, which demonstrate how agile we can be as an organization while executing concurrently on two transformative acquisitions,” said Vincent A. Forlenza, Chairman and CEO. “We enter fiscal 2019 with continued strong momentum and confidence in our ability to execute on our strategy, deliver on our commitments and create value for our shareholders.”
The following information was filed by Becton Dickinson Co (BDX) on Tuesday, November 6, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Becton Dickinson Co's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Becton Dickinson Co.
Becton Dickinson Co
Email AlertsAnnual Reports
- 10-K Annual Report November 2019
-
10-K Annual Report November 2018
- 10-K Annual Report November 2017
- 10-K Annual Report November 2016
- 10-K Annual Report November 2015
- 10-K Annual Report November 2014
- 10-K Annual Report November 2013
- 10-K Annual Report November 2012
- 10-K Annual Report November 2011
- 10-K Annual Report November 2010
